Human papillomavirus: a highly prevalent sexually transmitted disease agent among female sex workers from Mexico City.

BACKGROUND: Cervical cancer, a human papillomavirus (HPV)-caused neoplasia, is highly prevalent in Mexico. GOAL: To determine the prevalence of HPV infection in female sex workers (FSW) from Mexico City and to assess the association between HPV infection and the characteristics of these women. STUDY DESIGN: A questionnaire was applied to 495 FSW. Cervical cell specimens were obtained for DNA amplification and hybridization to detect 27 HPV types. A risk factor analysis was performed. RESULTS: The overall prevalence of HPV infection was 48.9%. The prevalence of high-risk HPV types was 43%, whereas that of low-risk types was 24.6%. A total of 18.8% of study participants was infected with both high-risk and low-risk HPV types, and 28.5% were infected with two or more HPV types. Younger age and failure to use a condom were independently associated HPV risks (odds ratio, 7.3 and 2.3; 95% CI, 3.5-15.0 and 1.2-4.4, respectively). CONCLUSIONS: Infection with high-risk and multiple HPV types is high among Mexican FSW. This study corroborated a higher infection rate in younger women. A higher risk of HPV infection is also observed in women who have been involved with sex work for less than 1 year. However, condom use showed a protective effect against HPV infection.

Hepatitis B markers in men seeking human immunodeficiency virus antibody testing in Mexico City.

OBJECTIVES: To estimate the prevalence and associated risk factors of hepatitis B virus (HBV) serologic markers in 1,377 men with high-risk sexual behavior attending a center for human immunodeficiency virus (HIV) detection in Mexico City. METHODS: The study population consisted of all men who were tested for HIV from March to September, 1992. Study participants responded to a standardized questionnaire and provided a blood sample for serology. RESULTS: A total of 1.9% of the population were hepatitis B surface antigen (HBsAg) carriers, and there was a significant difference in HBsAg prevalence between HIV-negative (0.8%) and HIV-positive individuals (7.9%). Sexual preference was associated with HBsAg prevalence; only 0.3% of men who had female sexual partners exclusively were HBsAg carriers, compared with 4.8% of men who had male sexual partners exclusively. Prevalence of antibodies to hepatitis B core antigen (anti-HBc) was 15.4%. However, men who reported only female partners had a 4.6% prevalence, whereas men who had only male partners had a 30.4% prevalence. Logistic regression analysis demonstrated an association of anti-HBc prevalence with age, marital status, sexual preference, seropositivity for HIV, and antibodies to herpes simplex virus type 2. CONCLUSIONS: These data demonstrate that coinfection with HBV is common in the HIV-positive men studied. The highest prevalences of HBsAg and anti-HBc were observed among homosexual men. These results highlight the need to intensify safe-sex education campaigns and to promote hepatitis B vaccination especially among this population group.

[Prevalence of antibodies to Pneumocystis carinii in subjects with high risk behavior for AIDS]. / Prevalencia de anticuerpos contra Pneumocystis carinii en sujetos con prácticas de alto riesgo de SIDA.

P. carinii pneumonia affects more than 80% of patients with AIDS in developed countries. In Mexico this complication has been described in 12 to 23% of patients with AIDS, and it has been proposed that competitive disease such as TB and the low life expectancy of AIDS patients in Mexico are the possible explanations of this low percentage. However, in Mexico the frequency with which the population at risk of contracting AIDS is exposed to P. carinii is unknown. Therefore, we looked for P. carinii antibodies in a group of blood samples obtained in an AIDS detection center in Mexico City. A Western blot analysis was performed on 157 blood samples from homosexual and bisexual men and on 21 from female partners of HIV positive men. Positive results were obtained for 76.9% of the samples. No difference was observed in the frequency of P. carinii antibodies between HIV positive and negative individuals. Also, no differences by sex or age were found. Prevalence of P. carinii antibodies in this group is 76.9%, similar to that found in a comparable group in the U.S.